ethacrynic acid 25 mg

INDICATIONS AND USAGE Ethacrynic Acid Tablets, USP are indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome.

sciegen pharmaceuticals inc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] arthralgia` `[5] nausea` `[6] off label use` `[7] rheumatoid arthritis` `[8] headache` `[9] diarrhoea` `[10] rash`

2 years ago

OVAL WHITE S G 334

2 years ago

S G 334 OVAL WHITE

HOW SUPPLIED

ETHACRYNIC ACID Tablets, USP 25 mg, are white, capsule shaped scored (functional scoring) tablets debossed with 'SG' on scored side and '334' on the other side and supplied as Bottles of 30 tablets: NDC 50228-334-30 Bottles of 100 tablets: NDC 50228-334-10 Bottles of 1000 tablets: NDC 50228-334-01 Storage Store in a tightly closed container at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Manufactured by: ScieGen Pharmaceuticals Inc. Hauppauge, NY 11788 Rev: 11/19

More pills like OVAL S G 334

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

ethacrynic acid 25 mg

FDA Reported Adverse Reactions [1] drug ineffective [2] pain [3] fatigue [4] arthralgia [5] nausea [6] off label use [7] rheumatoid arthritis [8] headache [9] diarrhoea [10] rash

OVAL WHITE S G 334

S G 334 OVAL WHITE

More pills like OVAL S G 334

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] arthralgia` `[5] nausea` `[6] off label use` `[7] rheumatoid arthritis` `[8] headache` `[9] diarrhoea` `[10] rash`